WO1998018339A1 - Composition de chewing-gum et procede de production - Google Patents
Composition de chewing-gum et procede de production Download PDFInfo
- Publication number
- WO1998018339A1 WO1998018339A1 PCT/JP1997/003973 JP9703973W WO9818339A1 WO 1998018339 A1 WO1998018339 A1 WO 1998018339A1 JP 9703973 W JP9703973 W JP 9703973W WO 9818339 A1 WO9818339 A1 WO 9818339A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bone
- chewing gum
- calcium
- hydroxyapatite
- tricalcium phosphate
- Prior art date
Links
- 235000015218 chewing gum Nutrition 0.000 title claims abstract description 41
- 229940112822 chewing gum Drugs 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title abstract description 4
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 69
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 38
- 239000011707 mineral Substances 0.000 claims abstract description 38
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 31
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 30
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 27
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 27
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims abstract description 25
- 235000019731 tricalcium phosphate Nutrition 0.000 claims abstract description 25
- 229940078499 tricalcium phosphate Drugs 0.000 claims abstract description 25
- 241000251468 Actinopterygii Species 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 241000269851 Sarda sarda Species 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 abstract description 13
- 230000037118 bone strength Effects 0.000 abstract description 6
- 230000002087 whitening effect Effects 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 229910052791 calcium Inorganic materials 0.000 description 37
- 229960005069 calcium Drugs 0.000 description 37
- 239000011575 calcium Substances 0.000 description 37
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 36
- 235000010755 mineral Nutrition 0.000 description 32
- 239000002585 base Substances 0.000 description 14
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 11
- 229910052586 apatite Inorganic materials 0.000 description 10
- 239000000843 powder Substances 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- 235000011010 calcium phosphates Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 229910000389 calcium phosphate Inorganic materials 0.000 description 5
- 159000000007 calcium salts Chemical class 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical class [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229910001868 water Inorganic materials 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 230000003416 augmentation Effects 0.000 description 3
- -1 calcium phosphate compound Chemical class 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 229910021654 trace metal Inorganic materials 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- 239000001354 calcium citrate Substances 0.000 description 2
- 229960004256 calcium citrate Drugs 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 2
- 239000001362 calcium malate Substances 0.000 description 2
- 229940016114 calcium malate Drugs 0.000 description 2
- 235000011038 calcium malates Nutrition 0.000 description 2
- 239000000292 calcium oxide Substances 0.000 description 2
- 235000012255 calcium oxide Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 125000005586 carbonic acid group Chemical group 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000025 natural resin Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000011163 secondary particle Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 235000013337 tricalcium citrate Nutrition 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241001098054 Pollachius pollachius Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 238000013001 point bending Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/064—Chewing gum characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
Definitions
- the present invention relates to a chewing gum composition and a method for producing the same. More specifically, the present invention relates to a chewing gum composition which is safe and effective for whitening teeth, enhancing tooth quality, preventing bad breath and the like while supplementing calcium, and a method for producing the same. Background art
- various calcium salts such as inorganic calcium salts such as calcium carbonate and organic calcium salts such as calcium citrate, calcium malate and calcium lactate are used as a calcium source.
- inorganic calcium salt calcium carbonate is used relatively frequently, but when dissolved in stomach acid, it produces carbon dioxide and strong alkali lime. This quicklime is immediately neutralized by acid in the stomach to form a salt such as calcium chloride. However, if ingested in large amounts, the quicklime remaining unneutralized may cause the pH in the stomach to rise excessively.
- Organic calcium salts such as calcium citrate, calcium malate, calcium lactate, etc. have good absorbency but low content of calcium per unit weight. In addition, all of the above substances conventionally used are for calcium supplementation alone.
- the substance that constitutes the inorganic components of the human skeleton and teeth consists of a calcium phosphate compound called apatite (bone apatite) composed of calcium, phosphorus, and water. Therefore, it is considered reasonable to supplement with a substance containing calcium and phosphorus at the same time, rather than supplementing with calcium alone, in order to strengthen tooth quality and increase bone strength. Furthermore, in recent times, diversification of lifestyles has led to an increase in demand for functional foods containing various types of nutrients that can be easily ingested.
- apatite bone apatite
- an object of the present invention is to provide a chewing gum composition as a functional food which is capable of safely supplementing calcium, and at the same time, is effective for strengthening teeth, increasing bone strength, and whitening teeth. It is in.
- Another object of the present invention is to provide a method for producing the above chewing gum composition.
- the present inventors have conducted intensive studies and as a result, have solved the above-mentioned problems by including bone mineral, at least one of tricalcium phosphate and hydroxyapatite in a gum base.
- the inventor has found that the present invention can be obtained, and based on this, has completed the present invention. Disclosure of the invention
- the present invention relates to a chewing gum composition characterized in that the gum base contains bone mineral and tricalcium phosphate and z or hydroxyapatite.
- the present invention provides a chewing gum production method comprising (I) a gum base production step, and (II) a step of adding and adding an ingredient to the gum base and forming and processing the same, wherein the bone mineral, tricalcium phosphate and
- the present invention relates to a method for producing a chewing gum composition, characterized in that it contains a hydroxyapatite.
- the chewing gum composition of the present invention contains bone mineral, tricalcium phosphate and Z or hydroxyapatite in a gum base.
- bone mineral refers to vertebrate bones such as sea urchins, bush, chickens, and various fishes that are chemically treated or heat-treated to remove organic substances and contain substantially only inorganic substances. It means what you have. Generally, when bones of animals and fish are dried to remove water, about 70% by weight of a substance called bone apatite containing phosphorus, potassium, and trace metal elements, and about 30% by weight of organic substances mainly composed of collagen Powder. Bone mineral refers to a powder obtained by removing the latter organic substance from the powder and extracting only bone abate containing trace metal elements. These bone minerals are preferable because they contain trace amounts of metals useful in human organisms, such as magnesium, stodium, iron, manganese, and zinc.
- metals useful in human organisms such as magnesium, stodium, iron, manganese, and zinc.
- Animal bones used to obtain bone minerals are not particularly limited, but they are characterized by the ease of processing, the uniformity of the calcium and phosphorus composition, and the availability of stable supplies. Therefore, those derived from fish are preferred.
- Fish include, for example, bonito, tuna, eso, cod, etc., but among them, mass production has already been established as a food additive, with little impurities and uniform composition (Cadiformes). Bone from the origin (cod bone), tuna, bonito and the like are preferred.
- Specific examples of cod include Madara, Alaska pollack, Sokodara, Chigodara and the like.
- the composition ratio of calcium and phosphorus (CaZP) in cod bone is 1.67, which is very similar to that in human bone.
- a bone mineral using cod can be obtained by the following method.
- the cod is heated, and the middle bone from which the fish meat has been removed is treated with an autoclave at a high temperature (around 120 ° C) and at a high pressure (about 2 atm or less) with hot water, and then treated with protease.
- a biochemical treatment such as a protein degradation treatment is performed, and a heat treatment is further performed to remove organic substances and to extract white bone apatite containing trace metal elements.
- Fish bones such as cod bones are small and fine, so biochemical treatment is weak.
- organic substances are completely removed by heat treatment at a low temperature of 800 ° C or less, and bone apatite with high whiteness, which is less likely to be gray due to incomplete firing, can be obtained. There are few impurities.
- This bone apatite is classified as a food additive into calcined fish bone powder, calcined bone calcium powder and the like.
- tricalcium phosphate [C a 3 (P 0 4) 2 ], one of hydroxyapatite [C a 1 () (P 0 4) 6 (OH) 2 ] 1 or more Above. All of these are safe and have high biocompatibility because the ratio of calcium to phosphorus is the same as or close to that of human bone.
- These tricalcium phosphate and hydroxyamate can be synthesized and produced by a known method.
- tricalcium phosphate and hydroxyapatite are preferably amorphous rather than crystalline.
- an amorphous material has a regular three-dimensional arrangement of atoms (the size of crystallites; almost the same as the size of primary particles in ceramics) is less than 200 nm (0.2 m). Is the name given to the substance. It is well known that calcium phosphate, such as hydroxyapatite, adsorbs proteins such as plaque, lipids, sugars, etc., especially when the specific surface area is large, it removes plaque that leads to whitening of teeth, It is effective for remineralization which leads to quality enhancement.
- Powder particle size of hydroxyapatite Ya tricalcium phosphate is found using the present invention in the following amorphous 1 / m, preferably in the range specific surface area of about 1 0 ⁇ 1 0 O m 2, to disperse additives In this case, it is desirable that the fine particles have a secondary particle diameter of 50 or less.
- Bone apatite (bone mineral) and hydroxyapatite are different in composition and are distinguished. Pure hydroxyapatite is represented by C a 1 0 (P 0 4 ) 6 (OH) 2.
- bone apatite is a type of carbonated hydroxyapatite in which the phosphate group of pure hydroxyapatite is substituted with 1 to 3% of carbonic acid groups (mineral name: darite). High solubility. Bone apatite has less calcium than pure hydroxyapatite, and is replaced by atoms such as hydrogen, magnesium, and sodium, and is called calcium-deficient apatite (h).
- hydroxyl groups are replaced by carbonic acid groups, chlorine atoms, fluorine atoms, etc.
- Those in which all of the hydroxyl groups are replaced by chlorine atoms are called chloroapatite, and those in which they are replaced by fluorine atoms are called fluorapatite.
- the “bone mineral” of the present invention includes those in which part or all of these hydroxyl groups are substituted with other atoms or the like.
- the total amount of the bone mineral, the calcium phosphate and / or the hydroxyapatite is preferably 1 to 20% by weight, more preferably 4 to 10% by weight in the chewing gum composition. %. If the amount is too small, it is difficult to obtain a sufficient effect of the present invention. As a result, there is a risk of causing an adverse effect of excessive calcium, and the texture becomes inferior.
- the mixing ratio (weight ratio) of bone mineral: (tricalcium phosphate and / or hydroxyapatite) is preferably 10:;! To 1:10, more preferably 7: 3 to 3: 7
- calcium phosphates such as tricalcium phosphate and hydroxyapatite alone do not contain minerals that increase bone strength. Bone minerals vary considerably in impurities and whiteness depending on the type of animal or fish, and when added to food, have a considerable effect on the appearance and the like.
- about 40% by weight of bone mineral, tricalcium phosphate, and hydroxyapatite is calcium.
- 60 O mg of bone mineral and calcium phosphate contain 24 O mg of calcium. More than 50% by weight of this calcium amount is adsorbed and left on the gum base, and usually less than 50% by weight enters the oral cavity. Therefore, the amount of calcium that can be consumed from one chewing gum is less than 12 O mg. This is 1/5 to 1777 of the daily calcium required by adults, 600 to 800: 11. Excessive calcium intake is considered safe and appropriate as the amount of calcium consumed by a single chewing gum because of the concern of over-neutralizing stomach acid and promoting the formation of pathological stones such as urinary stones.
- the chewing gum composition of the present invention may optionally contain additional components that can be usually contained in the chewing gum composition as long as the effects of the present invention are not impaired. Further, the effects of the present invention can be further enhanced by blending, for example, vitamin C, vitamin D, dextranase, and the like.
- the chewing gum of the present invention has a combined effect of preventing osteoporosis, promoting the development of teeth and jawbones, and whitening and strengthening teeth.
- the method for producing a chewing gum composition of the present invention includes a step of producing a gum base, a step of adding an additive component to the gum base, and forming and processing the same.
- a natural resin which is usually used for a gum base
- a stirrer stirrer
- the heating temperature is about 110 to 13 o ° c
- the dehydration is performed for about 10 to 15 hours.
- the dehydrated natural resin and the desired gum base material are sequentially charged into the heated kneader. Mix and dissolve them at about 110 to 130 ° C for 3 to 5 hours until uniform.
- this gum base contains bone mineral and tricalcium phosphate and Z or hydroxyapatite.
- the gum base thus obtained is formed and processed.
- mix the gum base and other optional ingredients such as sugars
- a mixer For example, when adding saccharides, usually, 1 to 2 of the compounding amount is added, kneaded for about 10 minutes, and then the remaining saccharides and a softener are added. The mixture is stirred for 30 to 40 minutes and finally the flavor is added, stirred for 1 to 2 minutes and removed.
- the finishing temperature of the gum is preferably about 40 to 60 ° C.
- This gum is put into an extruder and extruded into a strip with a thickness of 20 to 40 mm and a width of 400 to 47 mm, and then rolled while dusting the powdered sugar on the front and back surfaces. Through to a sheet of 1.5-2.5 mm thickness. This is cut into a desired size, aged and then packaged to obtain a chewing gum composition.
- a chewing gum having the composition (% by weight) shown in Table 1 below was produced by a conventional method.
- the average particle size of the used tricalcium phosphate and hydroxyapatite (1 Secondary particle diameter) was about 0.2 m.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP52030298A JP3911526B2 (ja) | 1996-10-31 | 1997-10-31 | チューインガム組成物およびその製造方法 |
AU47264/97A AU4726497A (en) | 1996-10-31 | 1997-10-31 | Chewing gum composition and process for the production thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30588096 | 1996-10-31 | ||
JP8/305880 | 1996-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998018339A1 true WO1998018339A1 (fr) | 1998-05-07 |
Family
ID=17950443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1997/003973 WO1998018339A1 (fr) | 1996-10-31 | 1997-10-31 | Composition de chewing-gum et procede de production |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP3911526B2 (fr) |
CN (1) | CN1086917C (fr) |
AU (1) | AU4726497A (fr) |
WO (1) | WO1998018339A1 (fr) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6471945B2 (en) | 2000-03-10 | 2002-10-29 | Warner-Lambert Company | Stain removing chewing gum and confectionery compositions, and methods of making and using the same |
US6485739B2 (en) | 2000-03-10 | 2002-11-26 | Warner-Lambert Company | Stain removing chewing gum and confectionery compositions, and methods of making and using the same |
US6869614B2 (en) | 1999-09-20 | 2005-03-22 | Jack Barreca | Chewing gum containing calcium |
WO2006038315A1 (fr) * | 2004-10-07 | 2006-04-13 | Kabushiki Kaisha Sangi | Préparation pour absorption percutanée/permuqueuse |
US7727565B2 (en) | 2004-08-25 | 2010-06-01 | Cadbury Adams Usa Llc | Liquid-filled chewing gum composition |
US8133476B2 (en) | 2006-04-05 | 2012-03-13 | Cadbury Adams Usa Llc | Calcium phosphate complex and salts in oral delivery systems |
US8252269B2 (en) | 2006-04-05 | 2012-08-28 | Cadbury Adams Usa, Llc | Impact of calcium phosphate complex on dental caries |
US8293274B2 (en) | 2005-04-06 | 2012-10-23 | Kabushiki Kaisha Sangi | Intestinal absorptive anti-tumor agent |
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
US9271904B2 (en) | 2003-11-21 | 2016-03-01 | Intercontinental Great Brands Llc | Controlled release oral delivery systems |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8590116B2 (en) | 2009-12-24 | 2013-11-26 | Jeffery Dahl | Loop rope assembly |
DE202013001426U1 (de) * | 2013-02-14 | 2013-04-10 | Sandro Raisun | Vitaminhaltiger Kaugummi |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57125676A (en) * | 1981-01-29 | 1982-08-05 | Hideki Sugioka | Preparation of powdered calcium compound used as a food additive |
JPS6371151A (ja) * | 1986-09-09 | 1988-03-31 | ワ−ナ−‐ランバ−ト・コンパニ− | チューインガム |
JPH03133341A (ja) * | 1989-10-18 | 1991-06-06 | Sangi:Kk | カルシウム補給用チューインガム |
JPH04121166A (ja) * | 1990-09-10 | 1992-04-22 | San Beesu Food Kk | 食用骨粉の製造方法 |
JPH05252904A (ja) * | 1992-03-12 | 1993-10-05 | Yamanouchi Pharmaceut Co Ltd | 焼成骨粉の顆粒及びその製造方法 |
JPH05276873A (ja) * | 1992-04-02 | 1993-10-26 | Fujimi Green Eng Kk | 歯磨ガム |
-
1997
- 1997-10-31 AU AU47264/97A patent/AU4726497A/en not_active Abandoned
- 1997-10-31 JP JP52030298A patent/JP3911526B2/ja not_active Expired - Fee Related
- 1997-10-31 WO PCT/JP1997/003973 patent/WO1998018339A1/fr active Application Filing
- 1997-10-31 CN CN97199312A patent/CN1086917C/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57125676A (en) * | 1981-01-29 | 1982-08-05 | Hideki Sugioka | Preparation of powdered calcium compound used as a food additive |
JPS6371151A (ja) * | 1986-09-09 | 1988-03-31 | ワ−ナ−‐ランバ−ト・コンパニ− | チューインガム |
JPH03133341A (ja) * | 1989-10-18 | 1991-06-06 | Sangi:Kk | カルシウム補給用チューインガム |
JPH04121166A (ja) * | 1990-09-10 | 1992-04-22 | San Beesu Food Kk | 食用骨粉の製造方法 |
JPH05252904A (ja) * | 1992-03-12 | 1993-10-05 | Yamanouchi Pharmaceut Co Ltd | 焼成骨粉の顆粒及びその製造方法 |
JPH05276873A (ja) * | 1992-04-02 | 1993-10-26 | Fujimi Green Eng Kk | 歯磨ガム |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
US6869614B2 (en) | 1999-09-20 | 2005-03-22 | Jack Barreca | Chewing gum containing calcium |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
US7351425B2 (en) | 1999-09-20 | 2008-04-01 | Jack Barreca | Confectionary product containing functional ingredients |
US6485739B2 (en) | 2000-03-10 | 2002-11-26 | Warner-Lambert Company | Stain removing chewing gum and confectionery compositions, and methods of making and using the same |
US6696044B2 (en) | 2000-03-10 | 2004-02-24 | Cadbury Adams Usa Llc | Stain removing chewing gum and confectionery compositions, and methods of making and using the same |
US6471945B2 (en) | 2000-03-10 | 2002-10-29 | Warner-Lambert Company | Stain removing chewing gum and confectionery compositions, and methods of making and using the same |
US9271904B2 (en) | 2003-11-21 | 2016-03-01 | Intercontinental Great Brands Llc | Controlled release oral delivery systems |
US7727565B2 (en) | 2004-08-25 | 2010-06-01 | Cadbury Adams Usa Llc | Liquid-filled chewing gum composition |
JPWO2006038315A1 (ja) * | 2004-10-07 | 2008-07-31 | 株式会社サンギ | 経皮・経粘膜吸収製剤 |
WO2006038315A1 (fr) * | 2004-10-07 | 2006-04-13 | Kabushiki Kaisha Sangi | Préparation pour absorption percutanée/permuqueuse |
US8293274B2 (en) | 2005-04-06 | 2012-10-23 | Kabushiki Kaisha Sangi | Intestinal absorptive anti-tumor agent |
US8252269B2 (en) | 2006-04-05 | 2012-08-28 | Cadbury Adams Usa, Llc | Impact of calcium phosphate complex on dental caries |
US8133476B2 (en) | 2006-04-05 | 2012-03-13 | Cadbury Adams Usa Llc | Calcium phosphate complex and salts in oral delivery systems |
Also Published As
Publication number | Publication date |
---|---|
JP3911526B2 (ja) | 2007-05-09 |
AU4726497A (en) | 1998-05-22 |
CN1086917C (zh) | 2002-07-03 |
CN1235519A (zh) | 1999-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3911526B2 (ja) | チューインガム組成物およびその製造方法 | |
MX2009002503A (es) | Composicion que sirve como suplemento alimenticio que contiene uno o mas compuestos de vitamina d3 y una o mas sales de magnesio. | |
JPH09107917A (ja) | 低う蝕性栄養組成物 | |
JP2005119983A (ja) | 栄養組成物 | |
AU2011206921B2 (en) | Multi-component pet food and method of manufacturing solid component | |
AU2004281513B2 (en) | Chewable compound for the remineralisation of tooth enamel | |
JPH0967262A (ja) | 皮膚賦活剤及び皮膚賦活食品 | |
EP0839459B1 (fr) | Composition contenant du calcium facilement absorbable et son procede de fabrication | |
JP3131385B2 (ja) | 易吸収性カルシウムを含有する組成物およびその製造方法 | |
US20040048925A1 (en) | Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives | |
JP4926245B2 (ja) | 透明飲料用のカルシウム強化物質 | |
JPH1189541A (ja) | 塩基性ミネラル含有経口摂取用組成物 | |
EP0377119A1 (fr) | Agent pour la réduction d'effets désavantageuses de sel de table | |
JP5053624B2 (ja) | 歯質強化剤及びその製造方法 | |
TW460285B (en) | A process for preparing calcium containing composition with high oral bioavailability | |
KR102428137B1 (ko) | 칼슘 보충용 조성물 | |
JPH09271356A (ja) | マグネシウムを含有するカルシウム組成物 | |
CN1101227A (zh) | 一种饲料添加剂 | |
JP2003063970A (ja) | 抗骨粗鬆症組成物 | |
JP6479547B2 (ja) | 動物用デンタルケア用組成物 | |
JP2022087490A (ja) | コラーゲン類吸収促進剤及びコラーゲン類の吸収を促進する方法 | |
AU713772B2 (en) | Calcium-containing foods | |
CN1210690A (zh) | 补钙饮食和调味剂 | |
Jansen | Experimental Dental Caries in Animals | |
JP2002255783A (ja) | 貝化石水を含有する化粧品の製法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97199312.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |